Average Co-Inventor Count = 3.99
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (43 from 1,777 patents)
2. Other (9 from 832,680 patents)
3. Transtech Pharma, Inc. (3 from 49 patents)
4. Eli Lilly and Company (2 from 4,442 patents)
5. High Point Pharmaceuticals, LLC (2 from 50 patents)
6. Novo Novdisk A/s (1 from 1 patent)
60 patents:
1. RE45670 - Aryl carbonyl derivatives as therapeutic agents
2. RE45183 - Heteroaryl-ureas and their use as glucokinase activators
3. 8586614 - Urea glucokinase activators
4. 8263634 - Heteroaryl-ureas and their use as glucokinase activators
5. 8148412 - Heteroaromatic glucokinase activators
6. 8148413 - N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
7. 8063081 - Aryl carbonyl derivatives as therapeutic agents
8. 7999114 - Dicycloalkylcarbamoyl ureas as glucokinase activators
9. 7897628 - Aryl carbonyl derivatives as therapeutic agents
10. 7884210 - Ureido-thiazole glucokinase activators
11. 7880012 - Benzamide glucokinase activators
12. 7872139 - Heteroaryl-ureas and their use as glucokinase activators
13. 7851636 - Heteroaryl-ureas and their use as glucokinase activators
14. 7816385 - Dimeric dicarboxylic acid derivatives, their preparation and use
15. 7812043 - N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes